BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tan RZH, Lockart I, Abdel Shaheed C, Danta M. Systematic review with meta-analysis: The effects of non-steroidal anti-inflammatory drugs and anti-platelet therapy on the incidence and recurrence of hepatocellular carcinoma. Aliment Pharmacol Ther 2021;54:356-67. [PMID: 34247393 DOI: 10.1111/apt.16515] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Nierengarten MB. Aspirin decreases the risk of hepatocellular cancer in at-risk patients. Cancer 2022;128:214-5. [PMID: 34990011 DOI: 10.1002/cncr.34069] [Reference Citation Analysis]
2 Guan R, Sun B, Wang Z, Zhou C, Yang Z, Gan W, Huang J, Liu G, Zhou J, Fan J, Yi Y, Qiu S. Antiviral therapy improves postoperative survival of patients with HBV-related hepatocellular carcinoma. The American Journal of Surgery 2022. [DOI: 10.1016/j.amjsurg.2022.01.008] [Reference Citation Analysis]
3 Danta M, Tan RZH, Lockart I, Abdel Shaheed C. Editorial: aspirin and NSAID for chemoprevention of hepatocellular carcinoma - ready for their use? Authors' reply. Aliment Pharmacol Ther 2021;54:852-3. [PMID: 34425011 DOI: 10.1111/apt.16568] [Reference Citation Analysis]
4 Amano H, Kanda T, Mochizuki H, Kojima Y, Suzuki Y, Hosoda K, Ashizawa H, Miura Y, Tsunoda S, Hirotsu Y, Ohyama H, Kato N, Moriyama M, Obi S, Omata M. The Use of Electronic Medical Records-Based Big-Data Informatics to Describe ALT Elevations Higher than 1000 IU/L in Patients with or without Hepatitis B Virus Infection. Viruses 2021;13:2216. [PMID: 34835022 DOI: 10.3390/v13112216] [Reference Citation Analysis]
5 Da Fonseca LG, Forner A. Editorial: aspirin and NSAID for chemoprevention of hepatocellular carcinoma-ready for their use? Aliment Pharmacol Ther 2021;54:850-1. [PMID: 34425013 DOI: 10.1111/apt.16556] [Reference Citation Analysis]
6 Ielasi L, Tovoli F, Tonnini M, Tortora R, Magini G, Sacco R, Pressiani T, Trevisani F, Sansone V, Marasco G, Piscaglia F, Granito A. Beneficial Prognostic Effects of Aspirin in Patients Receiving Sorafenib for Hepatocellular Carcinoma: A Tale of Multiple Confounders. Cancers (Basel) 2021;13:6376. [PMID: 34944996 DOI: 10.3390/cancers13246376] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]